Picture of Mithra Pharmaceuticals SA logo

MITRA — Mithra Pharmaceuticals SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Mithra Issues A Put Option Notice Under Capital Agreement With LDA Capital

May 13 (Reuters) - Mithra Pharmaceuticals SA  MITRA.BR :
    * ISSUES A PUT OPTION NOTICE UNDER CAPITAL AGREEMENT WITH
LDA
CAPITAL
    * UNDER TERMS OF THIS AGREEMENT EXTENDED IN APRIL 2022, LDA
CAPITAL COMMITS AN AMOUNT OF UP TO EUR 75 MILLION IN CASH WITHIN
A MAXIMUM OF FIVE YEARS (UNTIL APRIL 2025) IN EXCHANGE FOR NEW
ORDINARY SHARES IN MITHRA
    * THE FIRST THREE DRAWINGS RESULTED IN THE ISSUANCE OF
916,153
SHARES FOR A TOTAL AMOUNT OF APPROXIMATELY EUR 17 MILLION,
LEAVING EUR 58 MILLION AVAILABLE TO MITHRA
    * THE COMPLETION OF THE CAPITAL INCREASE IS SUBJECT TO THE
SUBSCRIPTION OF THE NEW SHARES BY LDA CAPITAL, AMOUNTING TO A
MAXIMUM OF 625,000 NEW SHARES, AND FOR A MAXIMUM AMOUNT OF EUR 5
MILLION.

Source text: https://bit.ly/3FESDHQ
Further company coverage:  MITRA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Mithra Pharmaceuticals SA

See all news